Metformin - The Drug for the Treatment of Autoimmune Diseases; A New Use of a Known Anti-Diabetic Drug

E-ISSN： 1873-4294|16|19|2223-2230

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.19, 2016-08, pp. : 2223-2230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy

Current Cancer Drug Targets, Vol. 14, Iss. 8, 2014-10 ,pp. : 727-736

Bentham Science Publishers

Access to resources Recommend Favorite

The lysosome among targets of metformin: new anti-inflammatory uses for an old drug?

By Lockwood Thomas D

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 5, 2010-05 ,pp. : 467-478

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Drug Delivery Systems for Anti-Diabetic Drugs: A Review

Current Drug Delivery, Vol. 11, Iss. 4, 2014-06 ,pp. : 444-457

Bentham Science Publishers

Access to resources Recommend Favorite

Stability Indicating HPTLC Method for the Estimation of Anti-diabetic Drug Teneligliptin

Current Pharmaceutical Analysis, Vol. 14, Iss. 6, 2018-11 ,pp. : 547-554

Bentham Science Publishers

Access to resources Recommend Favorite

The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K + channels and insulin secretion: comparison with the sulfonylureas and nateglinide

By Sunaga Y. Gonoi T. Shibasaki T. Ichikawa K. Kusama H. Yano H. Seino S.

European Journal of Pharmacology, Vol. 431, Iss. 1, 2001-11 ,pp. : 119-125

Elsevier

Access to resources Recommend Favorite